Area of research
Immunology · Oncology
Research interest
Research focused on Cancer research and Pancreatic cancer, with related work in Melanoma, CD20, Fibroblast growth factor receptor. Notable publications include 'Tumor-associated B-cells induce tumor heterogeneity and therapy resistance', 'Targeting CD20 in Melanoma Patients at High Risk of Disease Recurrence', and 'Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer model'.
Cancer-associated cells release citrate to support tumour metastatic progression
Tumor-associated B-cells induce tumor heterogeneity and therapy resistance
Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer model
Targeting Fibroblast Growth Factor Receptor (FGFR) with BGJ398 in a Gastric Cancer Model.
PubMed 2015cited by 19position: middle
Targeting CD20 in Melanoma Patients at High Risk of Disease Recurrence
Targeting HSP90 by the novel inhibitor NVP-AUY922 reduces growth and angiogenesis of pancreatic cancer.
PubMed 2012cited by 35position: middle
Abstract 3211: Inhibition of Hsp90 impairs expression of VDAC in plasma and mitochondrial membrane influencing cancer cell metabolism